Skip to main content
Premium Trial:

Request an Annual Quote

Biochips: With Little Fanfare, Intel Enters Life Sciences Ring


Intel, which has until now stayed out of the genomics market melée, quietly slipped into the gene pool during the past year. Andy Berlin was hired to head up a 10-person biochip group, charged with, among other things, finding uses for MEMS in biology.

Berlin stresses that the biochip unit, Intel’s first foray into life sciences, is a research-only group. “Intel is not becoming a life sciences company tomorrow,” Berlin says. “Our mission is to go out and identify places where silicon technology and chip technology and biology and medicine are converging, and to reach out and help accelerate that convergence.”

Intel’s model so far has been to partner with life sciences companies such as Hyseq spinoff Callida to assist with chip development. With Callida, Berlin’s group “is studying the feasibility of doing whole-genome sequencing,” he says. He’s also interested in chip-based early diagnosis of disease.

Though it still falls into the advanced research category, Berlin says the industry can expect Intel to up the ante as feasibility studies show positive results and more opportunities arise. “You’ll probably see us start another group in … a year or two, probably at a lab next to a university,” he says.

— Adrienne Burke and Meredith Salisbury


The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.